Terms: = Ovarian cancer AND PAM50 AND Treatment
2 results:
1. Clinical and Genomic Implications of Luminal and Basal Subtypes Across Carcinomas.
Zhao SG; Chen WS; Das R; Chang SL; Tomlins SA; Chou J; Quigley DA; Dang HX; Barnard TJ; Mahal BA; Gibb EA; Liu Y; Davicioni E; Duska LR; Posadas EM; Jolly S; Spratt DE; Nguyen PL; Maher CA; Small EJ; Feng FY
Clin Cancer Res; 2019 Apr; 25(8):2450-2457. PubMed ID: 30573691
[TBL] [Abstract] [Full Text] [Related]
2. Biomarkers in Breast cancer: Where Are We and Where Are We Going?
Duffy MJ; Walsh S; McDermott EW; Crown J
Adv Clin Chem; 2015; 71():1-23. PubMed ID: 26411409
[TBL] [Abstract] [Full Text] [Related]
